Fulton Bank, N.A. Edwards Lifesciences Corp Transaction History

Fulton Bank, N.A.

$1.12 Billion
Q2 2024

A detailed history of Fulton Bank, N.A. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Fulton Bank, N.A. holds 6,222 shares of EW stock, worth $404,927. This represents 0.05% of its overall portfolio holdings.

Number of Shares

6,222

Previous 6,333 1.75%

Holding current value

$404,927

Previous $605,000 5.12%

% of portfolio

0.05%

Previous 0.06%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 09, 2024	SELL	$84.3 - $94.31 $9,357 - $10,468	-111 Reduced 1.75%	6,222 $574,000
Q1 2024 Apr 10, 2024	BUY	$72.54 - $95.56 $943 - $1,242	13 Added 0.21%	6,333 $605,000
Q4 2023 Jan 04, 2024	BUY	$61.71 - $77.76 $9,626 - $12,130	156 Added 2.53%	6,320 $481,000
Q3 2023 Oct 04, 2023	BUY	$69.28 - $93.38 $96,229 - $129,704	1,389 Added 29.09%	6,164 $427,000
Q2 2023 Jul 06, 2023	SELL	$81.41 - $94.33 $11,234 - $13,017	-138 Reduced 2.81%	4,775 $450,000
Q1 2023 Apr 06, 2023	BUY	$74.26 - $84.51 $59,185 - $67,354	797 Added 19.36%	4,913 $406,000
Q4 2022 Jan 05, 2023	SELL	$68.3 - $87.44 $32,715 - $41,883	-479 Reduced 10.42%	4,116 $307,000
Q3 2022 Oct 04, 2022	SELL	$82.37 - $107.29 $6,095 - $7,939	-74 Reduced 1.58%	4,595 $380,000
Q2 2022 Jul 07, 2022	SELL	$86.5 - $128.27 $8,044 - $11,929	-93 Reduced 1.95%	4,669 $444,000
Q1 2022 Apr 05, 2022	SELL	$101.96 - $128.34 $2,243 - $2,823	-22 Reduced 0.46%	4,762 $560,000
Q3 2021 Oct 05, 2021	BUY	$102.91 - $122.75 $15,127 - $18,044	147 Added 3.17%	4,784 $542,000
Q2 2021 Jul 06, 2021	SELL	$83.84 - $104.76 $33,452 - $41,799	-399 Reduced 7.92%	4,637 $481,000
Q1 2021 Apr 05, 2021	SELL	$78.68 - $90.67 $85,997 - $99,102	-1,093 Reduced 17.83%	5,036 $421,000
Q4 2020 Jan 07, 2021	SELL	$71.69 - $91.23 $38,712 - $49,264	-540 Reduced 8.1%	6,129 $559,000
Q3 2020 Oct 06, 2020	BUY	$67.19 - $87.44 $41,926 - $54,562	624 Added 10.32%	6,669 $533,000
Q2 2020 Jul 06, 2020	SELL	$57.54 - $76.95 $179,352 - $239,853	-3,117 Reduced 34.02%	6,045 $418,000
Q1 2020 Apr 03, 2020	SELL	$52.41 - $81.0 $80,554 - $124,497	-1,537 Reduced 14.37%	9,162 $1.73 Million
Q4 2019 Jan 24, 2020	SELL	$71.7 - $82.09 $11,758 - $13,462	-164 Reduced 1.51%	10,699 $2.5 Million
Q3 2019 Oct 03, 2019	SELL	$61.55 - $75.43 $12,186 - $14,935	-198 Reduced 1.79%	10,863 $2.39 Million
Q2 2019 Jul 03, 2019	SELL	$55.74 - $64.41 $120,955 - $139,769	-2,170 Reduced 16.4%	11,061 $2.04 Million
Q1 2019 Apr 03, 2019	SELL	$47.89 - $64.05 $9,003 - $12,041	-188 Reduced 1.4%	13,231 $2.53 Million
Q4 2018 Jan 03, 2019	SELL	$46.41 - $56.94 $5,940 - $7,288	-128 Reduced 0.94%	13,419 $2.06 Million
Q3 2018 Oct 03, 2018	SELL	$45.7 - $58.03 $20,656 - $26,229	-452 Reduced 3.23%	13,547 $2.36 Million
Q2 2018 Jul 10, 2018	SELL	$42.45 - $51.3 $34,129 - $41,245	-804 Reduced 5.43%	13,999 $2.04 Million
Q1 2018 May 02, 2018	SELL	$37.19 - $47.45 $3,867 - $4,934	-104 Reduced 0.7%	14,803 $2.07 Million
Q4 2017 Jan 04, 2018	SELL	$33.79 - $39.39 $2,027 - $2,363	-60 Reduced 0.4%	14,907 $1.68 Million
Q3 2017 Oct 04, 2017	BUY	$36.29 - $38.83 $543,152 - $581,168	14,967	14,967 $1.64 Million

Others Institutions Holding EW

# of Institutions

1,418

Shares Held

470M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.2B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fulton Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Fulton Bank, N.A. with notifications on news.

Account